Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets.
about
Channelopathies from mutations in the cardiac sodium channel protein complexDesmosome regulation and signaling in diseaseEffects of Persistent Atrial Fibrillation-Induced Electrical Remodeling on Atrial Electro-Mechanics - Insights from a 3D Model of the Human AtriaIonic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation.Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atriaPulmonary venous structural remodeling in a canine model of chronic atrial dilation due to mitral regurgitationDiseases caused by mutations in Nav1.5 interacting proteinsLow density lipoproteins promote unstable calcium handling accompanied by reduced SERCA2 and connexin-40 expression in cardiomyocytes.Heterogeneous and anisotropic integrative model of pulmonary veins: computational study of arrhythmogenic substrate for atrial fibrillationPharmacologic targets for atrial fibrillation.Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein modelSpontaneous high-frequency action potential.Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.Relationship between connexins and atrial activation during human atrial fibrillation.Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias.Heterogeneous three-dimensional anatomical and electrophysiological model of human atria.Effects of Na(+) channel and cell coupling abnormalities on vulnerability to reentry: a simulation study.
P2860
Q26824051-4B3B06DC-90D6-482F-99F1-627F7F869CCBQ27013675-C2FB2C3D-81F2-4EA7-AD7A-7F7FD282E695Q27346315-98D5DA93-E698-49AA-8730-F1FADFE92866Q30476498-DB59402A-D1D7-4782-8B2E-AEC27086060BQ30545769-AFA4E513-DB62-47DE-99B0-EC03C75F4C77Q33327500-1F06B074-3D85-4FA3-A45F-1118BB58B3B8Q34482816-D81951A1-B7A8-43C4-8AF8-B3EA648E9C2BQ34629465-7C52BDA4-8A26-471E-BBC8-A8DD22415B38Q36801442-4DD2E5E5-907C-48ED-B8B2-72973EC25C5AQ36936338-49588B77-B41C-49AA-826E-A4C77CBFEBA3Q37496128-C5D863B6-B54A-4774-B939-E99941D3D638Q37603463-B78AA54D-84BE-4619-8E41-335C37079A39Q37867552-22CA078C-6557-4BE1-A522-71F5A3ABC933Q43012937-C8D4A7B8-293D-4C72-B4AC-257400A94F1BQ47933334-2E051975-AFEB-404B-9D36-4B541335C4B2Q51025232-32B5CCA4-9405-47E8-B19F-E064BF62AB29Q51183132-4F93A06C-44D8-48E9-BF81-C8A1DE78071DQ52007736-EC32BBAC-3E99-48F7-84DF-0DF1C8AF1927
P2860
Cardiac gap junctions and connexins: their role in atrial fibrillation and potential as therapeutic targets.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@ast
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@en
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@nl
type
label
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@ast
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@en
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@nl
prefLabel
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@ast
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@en
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@nl
P1476
Cardiac gap junctions and conn ...... ential as therapeutic targets.
@en
P2093
Habo J Jongsma
Huub M W van der Velden
P304
P356
10.1016/S0008-6363(01)00557-0
P577
2002-05-01T00:00:00Z